SF-20 Score and Item Distributions in a Human Immunodeficiency Virus-seropositive Sample
Overview
Affiliations
The question of whether the full range of possible health states is measured by the Medical Outcomes Study (MOS) 20-Item Short-Form Health Survey (SF-20) in human immunodeficiency virus (HIV)-seropositive individuals is examined in this article. Ninety-five HIV-seropositive men (37 with asymptomatic infection, 58 with symptomatic infection) from two primary care practices were enrolled. Patients completed the SF-20 evaluating six dimensions of health status. Asymptomatic patients reveal substantial skew in score distributions for the dimensions of physical (-1.60), role (-1.19), and social (-1.13) functioning; no substantial skew is exhibited by symptomatic patients. Both subgroups reveal ceiling effects for physical, role, and social functioning, and pain dimensions; asymptomatic patients' ceiling effects are higher (physical functioning: 65% versus 31%; role functioning: 73% versus 41%; social functioning: 54% versus 43%; and pain: 41% versus 24%). Patients from both subgroups reveal floor effects for the role functioning dimension (asymptomatic patients, 22%; symptomatic patients, 34%). When looking at items rather than scales, asymptomatic patients' item distributions for the physical, role, and social functioning, and pain dimensions reveal clustering toward positive health states in most items; distributions of symptomatic patients are similar. Because this HIV-seropositive sample exhibits substantial ceiling effects in four of six SF-20 dimensions, effects that particularly are notable for asymptomatic patients, these dimensions should be revised for use in HIV-seropositive individuals or a disease-specific quality of life instrument should be constructed.
Shilbayeh S, Ibrahim A Health Qual Life Outcomes. 2020; 18(1):215.
PMID: 32631346 PMC: 7339378. DOI: 10.1186/s12955-020-01471-4.
Engelbrecht M, Rau A, Nel P, Wilke M Int J Nurs Pract. 2019; 26(1):e12783.
PMID: 31512344 PMC: 9285812. DOI: 10.1111/ijn.12783.
Xue W, Zhang P, Zou H Int J Ophthalmol. 2019; 12(3):504-509.
PMID: 30918822 PMC: 6423376. DOI: 10.18240/ijo.2019.03.23.
Huang C, Chen W, Tsai M, Wang W Health Qual Life Outcomes. 2017; 15(1):238.
PMID: 29212511 PMC: 5717837. DOI: 10.1186/s12955-017-0814-6.
Development of a Performance-Based Measure of Executive Functions in Patients with Schizophrenia.
Chiu E, Lee S, Kuo C, Lung F, Hsueh I, Hsieh C PLoS One. 2015; 10(11):e0142790.
PMID: 26561862 PMC: 4642955. DOI: 10.1371/journal.pone.0142790.